MODERNA FRIGOR di DI PRISCO LIBERATO C. srlBusiness Directories,Company Directories

Company Name: Corporate Name:	MODERNA FRIGOR di DI PRISCO LIBERATO & C. srl
Company Title:
Company Description:
Keywords to Search:
Company Address:	170, v. Nazionale Passanti,80040 Terzigno (NA) - Italia,,Italy
ZIP Code: Postal Code:
Telephone Number:
Fax Number:
Website:
Email:
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
MONTI & C. srl
MORANDO ELIO - IFIM
MOVING GLASS & METAL DESIGN srl

Next company profile:
MODULSYSTEM snc
M.V.R. INDUSTRY srl
M & M di GUGLIOTTA MONICA

Company News:

Pioneering mRNA technology - Moderna
Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines So, what is mRNA? Messenger RNA (mRNA) already exists in your body It carries a “message”–instructions that direct your cells what to do
Moderna - Wikipedia
Moderna, Inc ( məˈdɜːrnə mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines
Modernas new COVID vaccine was just approved by the FDA . . . - Fortune
Moderna, over the weekend, announced that the U S Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and
FDA approves Modernas next-generation COVID vaccine for adults 65 or older
The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator
Modernas new COVID-19 vaccine mNexspike approved by FDA, but theres a . . .
The U S approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option The new vaccine,
Moderna, Inc. (MRNA) - Yahoo Finance
Find the latest Moderna, Inc (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing
Our Story - Moderna
Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus
Moderna | History, Innovation, Challenges, Facts | Britannica Money
Moderna, Inc is a biotechnology company specializing in messenger RNA (mRNA) medicines and is best known for developing one of the first COVID-19 vaccines authorized for emergency use
Moderna COVID-19 Vaccine | FDA
Information about Moderna COVID-19 Vaccine, Bivalent Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older
Moderna Q2 Earnings Review: Downsizing Triggers Selloff, But Im Long . . .
Moderna, Inc 's Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0 1bn in revenue and a $(0 8bn) net loss Learn more on MRNA stock here